Approval Launch

Category
Continent
From
To
 
FDA Expands Asceniv Label to Include Pediatric Pat...

FDA Expands Asceniv Label to Include Pediatric Pat...

Category : Approval/Launch 6 May 2026

For companies operating in niche biologics, label expansion is often more valuable than new approval...
Novartis Secures EU Approval for Rhapsido: A New O...

Novartis Secures EU Approval for Rhapsido: A New O...

Category : Approval/Launch 28 April 2026

The treatment landscape for chronic spontaneous urticaria (CSU) just shifted. Novartis has secured E...
Johnson & Johnson’s IMAAVY Secures FDA Priority Re...

Johnson & Johnson’s IMAAVY Secures FDA Priority Re...

Category : Approval/Launch 28 April 2026

Johnson & Johnson has received Priority Review designation from the U.S. Food and Drug Administr...
Apotex, Orbicular & Gland Pharma Secure Dual ANDA...

Apotex, Orbicular & Gland Pharma Secure Dual ANDA...

Category : Approval/Launch 17 April 2026

In a market where complexity often deters competition, three companies have just executed a near tex...
GSK Expands Exdensur’s Reach in China: A New Optio...

GSK Expands Exdensur’s Reach in China: A New Optio...

Category : Approval/Launch 10 April 2026

Global biopharma leader GSK plc has secured another regulatory win in China. China’s Nation...

Categories

Latest Newsletter Post

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!